Bupivacaine liposome Injection and Insulin Degludec (U-100) Vials
Determining the interaction of Bupivacaine liposome Injection and Insulin Degludec (U-100) Vials and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bupivacaine liposome
Brand name: Exparel
Synonyms: Bupivacaine liposome, Bupivacaine (Liposomal)
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bupivacaine liposome Injection-Insulin Degludec (U-200) Prefilled Pens
- Bupivacaine liposome Injection-Insulin degludec and liraglutide
- Bupivacaine liposome Injection-Insulin degludec and liraglutide Subcutaneous
- Bupivacaine liposome Injection-Insulin degludec Subcutaneous
- Bupivacaine liposome Injection-Insulin detemir
- Bupivacaine liposome Injection-Insulin Detemir (Cartridges and Prefilled Syringes)
- Insulin Degludec (U-100) Vials-Bupivacaine Spinal
- Insulin Degludec (U-100) Vials-Buprenex
- Insulin Degludec (U-100) Vials-Buprenex injection - Buprenex
- Insulin Degludec (U-100) Vials-Buprenorphine
- Insulin Degludec (U-100) Vials-Buprenorphine and Naloxone
- Insulin Degludec (U-100) Vials-Buprenorphine and Naloxone Buccal Film